Sanofi
(NASDAQ:SNY)
$47.04
-0.11[-0.23%]
Last update: 9:29AM Get Real Time Here
Q1 2024 earnings tomorrow on Thu Apr 25th before the market open
Conference call scheduled tomorrow at 8:30 AM Click to view the webcast
Consensus Rating1
Outperform
Highest Price Target1
$60.00
Lowest Price Target1
$55.00
Consensus Price Target1
$28.75

Sanofi Stock (NASDAQ:SNY), Analyst Ratings, Price Targets, Predictions

Sanofi SA has a consensus price target of $28.75, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, Argus Research, and Deutsche Bank on January 23, 2024, March 27, 2023, and August 12, 2022. With an average price target of $38.33 between Morgan Stanley, Argus Research, and Deutsche Bank, there's an implied -19.74% downside for Sanofi SA from these 3 analyst ratings.

Analyst Trend
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
Argus Research
Deutsche Bank
SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Sanofi

date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert
01/23/2024SNYBuy Now
Sanofi
$47.7615.16%Morgan Stanley
Mark Purcell
→ $55Initiates → Equal-WeightGet Alert
03/27/2023SNYBuy Now
Sanofi
$47.7625.63%Argus Research
Jasper Hellweg
$55 → $60MaintainsBuyGet Alert
08/12/2022SNYBuy Now
Sanofi
$47.76—Deutsche Bank
Emmanuel Papadakis
—UpgradeSell → HoldGet Alert
09/27/2021SNYBuy Now
Sanofi
$47.76—SVB Leerink
Geoffrey Porges
—UpgradeMarket Perform → OutperformGet Alert

FAQ

Q

What is the target price for Sanofi (SNY)?

A

The latest price target for Sanofi (NASDAQ: SNY) was reported by Morgan Stanley on January 23, 2024. The analyst firm set a price target for $55.00 expecting SNY to rise to within 12 months (a possible 16.92% upside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Sanofi (SNY)?

A

The latest analyst rating for Sanofi (NASDAQ: SNY) was provided by Morgan Stanley, and Sanofi initiated their equal-weight rating.

Q

When was the last upgrade for Sanofi (SNY)?

A

The last upgrade for Sanofi SA happened on August 12, 2022 when Deutsche Bank raised their price target to N/A. Deutsche Bank previously had a sell for Sanofi SA.

Q

When was the last downgrade for Sanofi (SNY)?

A

There is no last downgrade for Sanofi.

Q

When is the next analyst rating going to be posted or updated for Sanofi (SNY)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sanofi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sanofi was filed on January 23, 2024 so you should expect the next rating to be made available sometime around January 23, 2025.

Q

Is the Analyst Rating Sanofi (SNY) correct?

A

While ratings are subjective and will change, the latest Sanofi (SNY) rating was a initiated with a price target of $0.00 to $55.00. The current price Sanofi (SNY) is trading at is $47.04, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch